Bleomycin hydrochloride is an antitumor antibiotic used for the treatment of various cancers, particularly squamous cell carcinomas; it functions as a DNA-damaging agent that inhibits DNA synthesis and induces single- and double-strand DNA breaks as well as apurinic/apyrimidinic sites; it is also used as a radiomimetic compound in genotoxicity studies and as a micronucleus inducer in human lymphocytes for in vitro research.